Anupriya Patel Launches National Formulary of India 2026
Anupriya Patel launches the National Formulary of India 2026 as the government approves the Biovigilance Programme for organ and tissue transplantation.
- Industrial talks | 22/09/2026 | By News Bureau
Interviews
Nitin Prabhakar, Managing Director (MD), Anton Paar India
Nitin Prabhakar, Managing Director (MD), Anton Paar India, puts stronger emphasis on how the company enables Indian pharmaceutical manufacturers to produce globally accepted, high-quality products rather than promot...
Harkaran Dhingra, Chief Executive Officer (CEO), DSS Takara Bio India
Precision medicine is redefining healthcare by enabling faster, more accurate and personalised treatment strategies. Harkaran Dhingra, CEO, DSS Takara Bio India, shares with Pharma Industrial India, insights on Indi...
Dr. Abha Doshi, Principal, MET Institute of Pharmacy
As India’s pharmaceutical sector continues to attract global investment, the role of pharmacy education has never been more important. Dr. Abha Doshi, Principal, MET IOP, speaks exclusively with Pharma Industr...
Articles
Every AI Decision Leaves a Footprint. Is Indian Pharma Industry Ready to Follow It?
As Artificial Intelligence becomes embedded in pharmaceutical R&D, manufacturing, quality, and pharmacovigilance, organisations must build continuous governance systems that make every AI-assisted decision as tr...
Infrastructure Requirements for Modern Life Science and Biotech Parks: What Drives Success?
As India’s bio economy expands, modern life science parks are emerging as key growth enablers. Specialised infrastructure, talent and innovation ecosystems are shaping the future of biotechnology and pharmaceu...
Specialised Manufacturing Infrastructure: A Key Differentiator in Pharmaceutical Production
As global buyers prioritise compliance, consistency and infrastructure over production scale, purpose-built pharmaceutical man
ufacturing facilities are emerging as the defining factor in winning trust, regul...
Blog
Building a Resilient Pharma Supply Chain in India: Challenges, Innovations and the Road Ahead
By Darshana Daga
PRIP Scheme Set for Rollout: Key Highlights of the INR 5,000 Cr Initiative
By Pharma Industrial India
Next events
Appointments
Saumen Chakraborty, Member Board of Directors, PREMAS BIOTECH
Premas Biotech announced the appointment of Saumen Chakraborty to the Premas Biotech Board of Directors. “I am delighte...
Silvia Steyrer-Grube, Chief Executive Officer, CEO, Coriolis Pharma
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development o...
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy